Literature DB >> 3742599

Presence of glucocorticoid receptors in cultured thymic epithelial cells.

M Dardenne, T Itoh, F Homo-Delarche.   

Abstract

We investigated the presence of glucocorticoid receptors (GC) in human thymic epithelial cells grown in primary cultures and in a pure epithelial rat cell line. These GR levels were compared to those determined concomitantly in fresh human thymocytes. The average number of sites were 54,457/cell for males (n = 8) and 58,224/cell for females (n = 8) with mean Kd values of 1.5 and 1.7 X 10(-8) M, respectively, in cultured human epithelial cells. These results are comparable to those obtained for rat thymic epithelial cells. Competition experiments showed that the relative affinities of the steroids tested were in decreasing order: dexamethasone greater than progesterone greater than testosterone and estradiol. This observation is compatible with binding to physiological GR. Moreover, the mean GR value appeared to be approximately 10 times higher for human thymic epithelial cells than for thymocytes. Thus, human epithelial cells as well as thymocytes should be considered as a specific target for glucocorticoid hormones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742599     DOI: 10.1016/0008-8749(86)90011-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

Review 1.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

Review 2.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Wnt-4 protects thymic epithelial cells against dexamethasone-induced senescence.

Authors:  Gergely Talaber; Krisztian Kvell; Zoltan Varecza; Ferenc Boldizsar; Sonia M Parnell; Eric J Jenkinson; Graham Anderson; Timea Berki; Judit E Pongracz
Journal:  Rejuvenation Res       Date:  2011-03-31       Impact factor: 4.663

4.  Interleukin-21 accelerates thymic recovery from glucocorticoïd-induced atrophy.

Authors:  Moutih Rafei; Maude Dumont-Lagacé; Alexandre Rouette; Claude Perreault
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

5.  Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.

Authors:  Lukas Kirzinger; Sandra Boy; Jörg Marienhagen; Gerhard Schuierer; Reiner Neu; Michael Ried; Hans-Stefan Hofmann; Karsten Wiebe; Philipp Ströbel; Christoph May; Julia Kleylein-Sohn; Claudia Baierlein; Ulrich Bogdahn; Alexander Marx; Berthold Schalke
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

Review 6.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.